Daniel E Snyder
5PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 05, 2021
Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio<sup>®</sup> Plus) against natural flea and tick infestations on dogs presented as veterinary patients in Europe.Sophie Forster, Scott Wiseman, Daniel E Snyder
|May 28, 2021
Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio<sup>®</sup> Plus) for the prevention of heartworm disease (Dirofilaria immitis) in client-owned dogs in the USA.Lisa M Young, Scott Wiseman, Elizabeth Crawley
|May 18, 2021
Effectiveness of Credelio<sup>®</sup> Plus, a novel chewable tablet containing milbemycin oxime and lotilaner for the treatment of larval and immature adult stages of Toxocara canis in experimentally infected dogs.Lisa M Young, Scott Wiseman, Elizabeth Crawley
|May 18, 2021
Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio<sup>®</sup> Plus) against natural intestinal nematode infections in dogs presented as veterinary patients in Europe.Brad Hayes, Scott Wiseman, Daniel E Snyder
|May 18, 2021
Effectiveness of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio<sup>®</sup> Plus) for the treatment of larval and immature adult stages of Ancylostoma caninum in experimentally infected dogs.Daniel E Snyder, Scott Wiseman, Elizabeth Crawley
Pageof 1
